Hirnamin



Indications and Reactions:

Role Indications Reactions
Secondary
Schizophrenia 25.3%
Depression 20.6%
Insomnia 11.9%
Schizophrenia, Paranoid Type 7.6%
Drug Use For Unknown Indication 4.3%
Constipation 3.1%
Anxiety 2.9%
Pyrexia 2.9%
Autism 2.7%
Epilepsy 2.7%
Prophylaxis 2.7%
Bipolar Disorder 2.5%
Pharyngitis 2.0%
Bipolar I Disorder 1.8%
Maternal Exposure During Pregnancy 1.6%
Diabetes Mellitus 1.3%
Psychomotor Hyperactivity 1.3%
Alcoholism 0.9%
Borderline Personality Disorder 0.9%
Hypercholesterolaemia 0.9%
Thrombocytopenia 20.0%
Syndactyly 8.3%
Tachycardia 8.3%
Somnolence Neonatal 6.7%
Cardiac Failure Acute 5.0%
Pulmonary Embolism 5.0%
Quadriplegia 5.0%
Rash 5.0%
Rash Generalised 5.0%
Suicide Attempt 5.0%
Hospitalisation 3.3%
Ileus 3.3%
Respiratory Disorder Neonatal 3.3%
Sensory Disturbance 3.3%
Treatment Noncompliance 3.3%
White Blood Cell Count Increased 3.3%
Autism 1.7%
Calcinosis 1.7%
Drug-induced Liver Injury 1.7%
Hyperprolactinaemia 1.7%
Concomitant
Schizophrenia 22.4%
Depression 15.6%
Drug Use For Unknown Indication 14.5%
Insomnia 13.3%
Product Used For Unknown Indication 4.5%
Prophylaxis 3.6%
Hiv Infection 3.2%
Constipation 2.4%
Hypertension 2.4%
Bipolar Disorder 2.2%
Bipolar I Disorder 2.1%
Sedation 1.8%
Diabetes Mellitus 1.7%
Cardiac Valve Disease 1.7%
Dissociative Disorder 1.7%
Schizophrenia, Disorganised Type 1.6%
Anxiety 1.4%
Schizophrenia, Catatonic Type 1.4%
Congestive Cardiomyopathy 1.3%
Schizophrenia, Paranoid Type 1.2%
White Blood Cell Count Decreased 21.1%
White Blood Cell Count Increased 9.9%
Fall 6.6%
Suicide Attempt 6.6%
Schizophrenia 5.9%
Drug Exposure During Pregnancy 4.6%
Inappropriate Schedule Of Drug Administration 3.9%
Pneumonia 3.9%
Pneumonia Aspiration 3.9%
Rhabdomyolysis 3.9%
Dehydration 3.3%
Renal Impairment 3.3%
Somnolence 3.3%
Tremor 3.3%
Water Intoxication 3.3%
Condition Aggravated 2.6%
Gastric Ulcer Haemorrhage 2.6%
Haemoptysis 2.6%
Hallucination 2.6%
Obesity 2.6%